No Data
No Data
BeiGene to Rebrand as BeOne Medicines With Oncology-Focused New Nasdaq Ticker "ONC"
Express News | Beigene - Will Change Its Nasdaq Ticker Symbol for Its American Depositary Shares From "Bgne" to "Onc" on Jan 2, 2025
BEIGENE (688235.SH): Plans to change the company's Nasdaq stock code to "ONC".
Gelonghui, December 23rd ┃ BEIGENE (688235.SH) announced that the company's American depositary shares traded on Nasdaq will change their stock code from "BGNE" to "ONC," effective from January 2, 2025, to emphasize the company's firm commitment to providing innovative oncology drugs globally. The stock code and abbreviated name on the Shanghai Stock Exchange and the stock code and abbreviated name on the Hong Kong Stock Exchange will remain unchanged. The change of the Nasdaq stock code can be implemented without submission for discussion at the company’s shareholder meeting.
BeiGene to Change Nasdaq Ticker Symbol to "ONC" on January 2; Present at 43rd Annual J.P. Morgan Healthcare Conference
Express News | Beigene to Change Nasdaq Ticker Symbol to “Onc” on January 2; Present at 43Rd Annual J.P. Morgan Healthcare Conference
BeiGene Gets FDA Orphan Designation in Waldenstrom Macroglobulinemia Treatment
No Data
Just Care Bears : I thought there’s a FDA approval going on on this today no news yet
Claudius NJIE Just Care Bears : yes good news is coming.
Claudius NJIE : pls run to at least 50